Bellevue Group
Latest statistics and disclosures from Bellevue Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IONS, ARGX, VRTX, NBIX, ISRG, and represent 23.90% of Bellevue Group's stock portfolio.
- Added to shares of these 10 stocks: SYK (+$33M), BHVN (+$31M), UNH (+$29M), PODD (+$29M), REGN (+$27M), EWTX (+$26M), RMD (+$24M), MCK (+$22M), PEN (+$18M), ZBH (+$18M).
- Started 10 new stock positions in KURA, ALT, WAY, EWTX, RARE, TEM, GRAL, LH, NKE, ARQT.
- Reduced shares in these 10 stocks: INSM (-$75M), ISRG (-$63M), ARGX (-$51M), BSX (-$45M), HUM (-$40M), VRTX (-$35M), Shockwave Med (-$34M), MRK (-$29M), TMDX (-$25M), ITCI (-$24M).
- Sold out of its positions in BAX, BMEA, BMY, IONQ, Laboratory Corp. of America Holdings, PACB, RGNX, SPY, Shockwave Med, SMPL. GDX, VERV, VRDN.
- Bellevue Group was a net seller of stock by $-279M.
- Bellevue Group has $6.2B in assets under management (AUM), dropping by -6.14%.
- Central Index Key (CIK): 0001674546
Tip: Access up to 7 years of quarterly data
Positions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Bellevue Group
Bellevue Group holds 166 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Ionis Pharmaceuticals (IONS) | 6.4 | $394M | 8.3M | 47.66 |
|
|
Argenx Se Sponsored Adr (ARGX) | 4.8 | $298M | -14% | 692k | 430.04 |
|
Vertex Pharmaceuticals Incorporated (VRTX) | 4.5 | $278M | -11% | 594k | 468.72 |
|
Neurocrine Biosciences (NBIX) | 4.2 | $261M | -7% | 1.9M | 137.67 |
|
Intuitive Surgical Com New (ISRG) | 3.9 | $240M | -20% | 540k | 444.85 |
|
Alnylam Pharmaceuticals (ALNY) | 3.6 | $224M | 920k | 243.00 |
|
|
Boston Scientific Corporation (BSX) | 3.2 | $198M | -18% | 2.6M | 77.01 |
|
Revolution Medicines (RVMD) | 3.2 | $195M | 5.0M | 38.81 |
|
|
Stryker Corporation (SYK) | 3.0 | $186M | +21% | 546k | 340.25 |
|
Moderna (MRNA) | 3.0 | $186M | -8% | 1.6M | 118.75 |
|
Intra Cellular Therapies (ITCI) | 2.8 | $169M | -12% | 2.5M | 68.49 |
|
Agios Pharmaceuticals (AGIO) | 2.7 | $167M | -3% | 3.9M | 43.12 |
|
Abbott Laboratories (ABT) | 2.7 | $167M | +11% | 1.6M | 103.91 |
|
Dex (DXCM) | 2.3 | $144M | +3% | 1.3M | 113.38 |
|
Incyte Corporation (INCY) | 2.1 | $131M | 2.2M | 60.62 |
|
|
Edwards Lifesciences (EW) | 1.9 | $116M | +14% | 1.3M | 92.37 |
|
Celldex Therapeutics Com New (CLDX) | 1.8 | $110M | +6% | 3.0M | 37.01 |
|
UnitedHealth (UNH) | 1.7 | $105M | +38% | 206k | 509.26 |
|
Insulet Corporation (PODD) | 1.4 | $88M | +48% | 435k | 201.80 |
|
Becton, Dickinson and (BDX) | 1.3 | $81M | -16% | 347k | 233.71 |
|
Medtronic SHS (MDT) | 1.3 | $79M | 1.0M | 78.71 |
|
|
Biohaven (BHVN) | 1.2 | $71M | +77% | 2.0M | 34.71 |
|
Insmed Com Par $.01 (INSM) | 1.1 | $69M | -52% | 1.0M | 67.00 |
|
Arvinas Ord (ARVN) | 1.0 | $64M | 2.4M | 26.62 |
|
|
Tandem Diabetes Care Com New (TNDM) | 1.0 | $62M | -24% | 1.5M | 40.29 |
|
Caredx (CDNA) | 1.0 | $61M | 3.9M | 15.53 |
|
|
Anthem (ELV) | 0.9 | $55M | +2% | 102k | 541.86 |
|
Penumbra (PEN) | 0.8 | $51M | +55% | 282k | 179.97 |
|
EXACT Sciences Corporation (EXAS) | 0.8 | $49M | 1.2M | 42.25 |
|
|
Zimmer Holdings (ZBH) | 0.8 | $49M | +59% | 449k | 108.53 |
|
Sage Therapeutics (SAGE) | 0.8 | $49M | 4.5M | 10.86 |
|
|
Charles River Laboratories (CRL) | 0.8 | $48M | 233k | 206.58 |
|
|
IDEXX Laboratories (IDXX) | 0.7 | $46M | 93k | 487.20 |
|
|
Eli Lilly & Co. (LLY) | 0.7 | $45M | -14% | 50k | 905.38 |
|
Bio Rad Labs Cl A (BIO) | 0.7 | $42M | 155k | 273.11 |
|
|
Macrogenics (MGNX) | 0.7 | $42M | 9.9M | 4.25 |
|
|
Axsome Therapeutics (AXSM) | 0.7 | $42M | -24% | 517k | 80.50 |
|
Relay Therapeutics (RLAY) | 0.7 | $42M | +7% | 6.4M | 6.52 |
|
Essa Pharma Com New (EPIX) | 0.7 | $42M | 7.9M | 5.26 |
|
|
Procept Biorobotics Corp (PRCT) | 0.7 | $41M | -24% | 669k | 61.09 |
|
Cigna Corp (CI) | 0.7 | $41M | +54% | 123k | 330.57 |
|
Ge Healthcare Technologies I Common Stock (GEHC) | 0.7 | $41M | 521k | 77.92 |
|
|
Exelixis (EXEL) | 0.7 | $41M | -5% | 1.8M | 22.47 |
|
Sarepta Therapeutics (SRPT) | 0.6 | $40M | 252k | 158.00 |
|
|
Black Diamond Therapeutics (BDTX) | 0.6 | $40M | 8.5M | 4.66 |
|
|
Hca Holdings (HCA) | 0.6 | $39M | -23% | 122k | 321.28 |
|
Option Care Health Com New (OPCH) | 0.6 | $39M | -24% | 1.4M | 27.70 |
|
Immunocore Hldgs Ads (IMCR) | 0.6 | $39M | +18% | 1.2M | 33.89 |
|
Align Technology (ALGN) | 0.6 | $35M | -7% | 144k | 241.43 |
|
Cooper Cos (COO) | 0.6 | $35M | 397k | 87.30 |
|
|
Globus Med Cl A (GMED) | 0.6 | $34M | -14% | 497k | 68.49 |
|
Regeneron Pharmaceuticals (REGN) | 0.6 | $34M | +356% | 32k | 1051.03 |
|
Crispr Therapeutics Namen Akt (CRSP) | 0.5 | $33M | 618k | 54.01 |
|
|
Beam Therapeutics (BEAM) | 0.5 | $33M | +18% | 1.4M | 23.43 |
|
Evolent Health Cl A (EVH) | 0.5 | $32M | +12% | 1.7M | 19.12 |
|
Veeva Sys Cl A Com (VEEV) | 0.5 | $31M | 169k | 183.01 |
|
|
Transmedics Group (TMDX) | 0.5 | $30M | -44% | 201k | 150.62 |
|
ResMed (RMD) | 0.5 | $30M | +412% | 156k | 191.42 |
|
Centene Corporation (CNC) | 0.5 | $28M | +16% | 422k | 66.30 |
|
McKesson Corporation (MCK) | 0.4 | $27M | +412% | 46k | 584.04 |
|
Castle Biosciences (CSTL) | 0.4 | $27M | 1.2M | 21.77 |
|
|
Edgewise Therapeutics (EWTX) | 0.4 | $26M | NEW | 1.4M | 18.01 |
|
Annexon (ANNX) | 0.4 | $25M | +136% | 5.2M | 4.90 |
|
Thermo Fisher Scientific (TMO) | 0.4 | $24M | +6% | 43k | 553.00 |
|
Natera (NTRA) | 0.4 | $23M | -20% | 214k | 108.29 |
|
Silk Road Medical Inc Common | 0.4 | $23M | -43% | 855k | 27.04 |
|
Molina Healthcare (MOH) | 0.4 | $23M | -23% | 76k | 297.30 |
|
Esperion Therapeutics (ESPR) | 0.4 | $22M | 9.9M | 2.22 |
|
|
Structure Therapeutics Sponsord Ads (GPCR) | 0.4 | $22M | +53% | 557k | 39.27 |
|
Danaher Corporation (DHR) | 0.3 | $21M | -2% | 84k | 249.85 |
|
Wave Life Sciences SHS (WVE) | 0.3 | $20M | 4.1M | 4.99 |
|
|
AmerisourceBergen (COR) | 0.3 | $20M | -32% | 89k | 225.30 |
|
Steris Shs Usd (STE) | 0.3 | $20M | +24% | 91k | 219.54 |
|
Hutchmed China Sponsored Ads (HCM) | 0.3 | $20M | 1.1M | 17.12 |
|
|
Iqvia Holdings (IQV) | 0.3 | $20M | +1004% | 92k | 211.44 |
|
Privia Health Group (PRVA) | 0.3 | $18M | 1.1M | 17.38 |
|
|
Hologic (HOLX) | 0.3 | $18M | -14% | 248k | 74.25 |
|
Scholar Rock Hldg Corp (SRRK) | 0.3 | $18M | 2.2M | 8.33 |
|
|
Si-bone (SIBN) | 0.3 | $18M | +21% | 1.4M | 12.93 |
|
Apellis Pharmaceuticals (APLS) | 0.3 | $17M | -6% | 444k | 38.36 |
|
Inspire Med Sys (INSP) | 0.3 | $17M | -42% | 125k | 133.83 |
|
Neogenomics Com New (NEO) | 0.3 | $17M | +27% | 1.2M | 13.87 |
|
Verona Pharma Sponsored Ads (VRNA) | 0.3 | $16M | 1.1M | 14.46 |
|
|
Legend Biotech Corp Sponsored Ads (LEGN) | 0.3 | $16M | +25% | 369k | 44.29 |
|
Fate Therapeutics (FATE) | 0.3 | $16M | 4.8M | 3.28 |
|
|
Generation Bio (GBIO) | 0.2 | $11M | 3.9M | 2.82 |
|
|
Humana (HUM) | 0.2 | $11M | -79% | 28k | 373.65 |
|
Astrana Health Com New (ASTH) | 0.2 | $10M | +2343% | 251k | 40.56 |
|
Phreesia (PHR) | 0.2 | $9.4M | 443k | 21.20 |
|
|
Merck & Co (MRK) | 0.2 | $9.2M | -75% | 75k | 123.80 |
|
Amgen (AMGN) | 0.1 | $9.2M | +33% | 30k | 312.45 |
|
Abbvie (ABBV) | 0.1 | $7.2M | +52% | 42k | 171.52 |
|
Glaukos (GKOS) | 0.1 | $6.6M | 56k | 118.35 |
|
|
Omnicell (OMCL) | 0.1 | $6.4M | 235k | 27.07 |
|
|
10x Genomics Cl A Com (TXG) | 0.1 | $6.0M | 308k | 19.45 |
|
|
AtriCure (ATRC) | 0.1 | $4.8M | -52% | 213k | 22.77 |
|
Illumina (ILMN) | 0.1 | $4.6M | 44k | 104.38 |
|
|
BioMarin Pharmaceutical (BMRN) | 0.1 | $4.3M | -83% | 52k | 82.33 |
|
Altimmune Com New (ALT) | 0.1 | $4.0M | NEW | 600k | 6.65 |
|
Beigene Sponsored Adr (BGNE) | 0.1 | $3.7M | +2% | 26k | 142.67 |
|
Astrazeneca Sponsored Adr (AZN) | 0.1 | $3.3M | +81% | 42k | 77.99 |
|
Waystar Holding Corp (WAY) | 0.1 | $3.2M | NEW | 150k | 21.50 |
|
Cardinal Health (CAH) | 0.1 | $3.2M | +986% | 33k | 98.32 |
|
Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $3.2M | 426k | 7.50 |
|
|
Accolade (ACCD) | 0.0 | $3.0M | -82% | 843k | 3.58 |
|
Outset Med (OM) | 0.0 | $2.9M | +33% | 763k | 3.85 |
|
Gilead Sciences (GILD) | 0.0 | $2.7M | +16% | 39k | 68.61 |
|
Teladoc (TDOC) | 0.0 | $2.7M | 273k | 9.78 |
|
|
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.0 | $2.5M | +8% | 155k | 16.25 |
|
Pfizer (PFE) | 0.0 | $2.5M | +161% | 89k | 27.98 |
|
Doximity Cl A (DOCS) | 0.0 | $2.0M | -49% | 72k | 27.97 |
|
Dr Reddys Labs Adr (RDY) | 0.0 | $1.8M | -42% | 23k | 76.19 |
|
Molecular Templates Com New (MTEM) | 0.0 | $1.5M | +24% | 1.3M | 1.15 |
|
Biogen Idec (BIIB) | 0.0 | $1.4M | 5.9k | 231.82 |
|
|
Certara Ord (CERT) | 0.0 | $1.3M | 96k | 13.85 |
|
|
CVS Caremark Corporation (CVS) | 0.0 | $1.3M | 22k | 59.06 |
|
|
Encompass Health Corp (EHC) | 0.0 | $1.2M | -7% | 14k | 85.79 |
|
Johnson & Johnson (JNJ) | 0.0 | $1.1M | +21% | 7.8k | 146.16 |
|
Nevro (NVRO) | 0.0 | $1.1M | 135k | 8.42 |
|
|
Alphabet Cap Stk Cl C (GOOG) | 0.0 | $1.1M | 6.0k | 183.42 |
|
|
Vaxcyte (PCVX) | 0.0 | $1.1M | +7% | 14k | 75.51 |
|
Cytokinetics Com New (CYTK) | 0.0 | $903k | +6% | 17k | 54.18 |
|
Krystal Biotech (KRYS) | 0.0 | $771k | -12% | 4.2k | 183.64 |
|
Tenet Healthcare Corp Com New (THC) | 0.0 | $720k | +27% | 5.4k | 133.03 |
|
Merus N V (MRUS) | 0.0 | $580k | 9.8k | 59.17 |
|
|
Blueprint Medicines (BPMC) | 0.0 | $550k | 5.1k | 107.78 |
|
|
Rhythm Pharmaceuticals (RYTM) | 0.0 | $534k | +4% | 13k | 41.06 |
|
Protagonist Therapeutics (PTGX) | 0.0 | $525k | -20% | 15k | 34.65 |
|
Zoetis Cl A (ZTS) | 0.0 | $510k | -60% | 2.9k | 173.36 |
|
Apple (AAPL) | 0.0 | $463k | 2.2k | 210.62 |
|
|
Alkermes SHS (ALKS) | 0.0 | $434k | -25% | 18k | 24.10 |
|
Rocket Pharmaceuticals (RCKT) | 0.0 | $424k | 20k | 21.53 |
|
|
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.0 | $399k | +38% | 63k | 6.35 |
|
Xenon Pharmaceuticals (XENE) | 0.0 | $398k | -27% | 10k | 38.99 |
|
Adma Biologics (ADMA) | 0.0 | $346k | -24% | 31k | 11.18 |
|
4d Molecular Therapeutics In (FDMT) | 0.0 | $330k | 16k | 20.99 |
|
|
Bridgebio Pharma (BBIO) | 0.0 | $324k | 13k | 25.33 |
|
|
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.0 | $324k | +28% | 16k | 20.24 |
|
Dynavax Technologies Corp Com New (DVAX) | 0.0 | $310k | 28k | 11.23 |
|
|
Madrigal Pharmaceuticals (MDGL) | 0.0 | $308k | +3% | 1.1k | 280.16 |
|
Viatris (VTRS) | 0.0 | $282k | +82% | 27k | 10.63 |
|
C4 Therapeutics Com Stk (CCCC) | 0.0 | $266k | 58k | 4.62 |
|
|
Nike CL B (NKE) | 0.0 | $264k | NEW | 3.5k | 75.37 |
|
Viking Therapeutics (VKTX) | 0.0 | $233k | -18% | 4.4k | 53.01 |
|
Kura Oncology (KURA) | 0.0 | $206k | NEW | 10k | 20.59 |
|
Mineralys Therapeutics (MLYS) | 0.0 | $205k | +90% | 18k | 11.70 |
|
Ideaya Biosciences (IDYA) | 0.0 | $200k | +72% | 5.7k | 35.11 |
|
89bio (ETNB) | 0.0 | $198k | +80% | 25k | 8.01 |
|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $194k | 4.4k | 43.97 |
|
|
Tempus Ai Cl A (TEM) | 0.0 | $175k | NEW | 5.0k | 35.00 |
|
Baidu Spon Adr Rep A (BIDU) | 0.0 | $173k | 2.0k | 86.48 |
|
|
West Pharmaceutical Services (WST) | 0.0 | $171k | -40% | 520.00 | 329.39 |
|
Garmin SHS (GRMN) | 0.0 | $171k | -62% | 1.1k | 162.92 |
|
Ultragenyx Pharmaceutical (RARE) | 0.0 | $164k | NEW | 4.0k | 41.10 |
|
Arcutis Biotherapeutics (ARQT) | 0.0 | $163k | NEW | 18k | 9.30 |
|
Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $113k | 33k | 3.48 |
|
|
Grail (GRAL) | 0.0 | $112k | NEW | 7.3k | 15.37 |
|
Agilent Technologies Inc C ommon (A) | 0.0 | $91k | +30% | 704.00 | 129.63 |
|
NVIDIA Corporation (NVDA) | 0.0 | $81k | +575% | 655.00 | 123.54 |
|
Oracle Corporation (ORCL) | 0.0 | $81k | -15% | 571.00 | 141.20 |
|
Microsoft Corporation (MSFT) | 0.0 | $80k | 179.00 | 446.95 |
|
|
Qualcomm (QCOM) | 0.0 | $78k | -24% | 391.00 | 199.18 |
|
Mettler-Toledo International (MTD) | 0.0 | $56k | +21% | 40.00 | 1397.60 |
|
Omniab (OABI) | 0.0 | $43k | 12k | 3.75 |
|
|
Labcorp Holdings Com Shs (LH) | 0.0 | $39k | NEW | 190.00 | 203.51 |
|
Exscientia Ads (EXAI) | 0.0 | $17k | +26% | 3.4k | 5.10 |
|
Past Filings by Bellevue Group
SEC 13F filings are viewable for Bellevue Group going back to 2016
- Bellevue Group 2024 Q2 filed Aug. 14, 2024
- Bellevue Group 2024 Q1 filed May 15, 2024
- Bellevue Group 2023 Q4 filed Feb. 14, 2024
- Bellevue Group 2023 Q3 filed Nov. 14, 2023
- Bellevue Group 2023 Q2 filed Aug. 14, 2023
- Bellevue Group 2023 Q1 filed May 15, 2023
- Bellevue Group 2022 Q4 filed Feb. 14, 2023
- Bellevue Group 2022 Q3 filed Nov. 14, 2022
- Bellevue Group 2022 Q2 filed Aug. 11, 2022
- Bellevue Group 2022 Q1 filed May 13, 2022
- Bellevue Group 2021 Q4 filed Feb. 10, 2022
- Bellevue Group 2021 Q3 filed Nov. 12, 2021
- Bellevue Group 2021 Q2 filed Aug. 12, 2021
- Bellevue Group 2021 Q1 filed May 12, 2021
- Bellevue Group 2020 Q4 filed Feb. 16, 2021
- Bellevue Group 2020 Q3 filed Nov. 16, 2020